A novel nasal mucosal peptide-modified co-delivery system for ginsenoside Rg1, Rb1, and notoginseng saponin R1 in the amelioration of AD.

已完结 20 由一条皮皮虫发布于 2026/11/5 19:47:19

DOI:10.1186/s12951-026-04532-w
作者：Yinjia Li,?Changhui Hu,?Chenjie Xia,?Xitong Wang,?Xuting Zhou,?Rui Xu,?Yunshu Li,?Feng Mo,?Binhao Zhao,?Liu Xu,?Chenqi Zhu,?Zhipeng Chen
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1186/s12951-026-04532-w

Springer

Abstract：The drug delivery for Alzheimer's disease (AD) faces substantial obstacles owing to the presence of the blood-brain barrier (BBB). This circumstance highlights the nose-brain route as pivota

应助信息

8小时前

同学羊小

63225db1d90f11f1980d208810ba6e4f.pdf 已采纳

8小时前

Book学术机器人

2026/11/5 19:47:20 未找到该文献，机器人已退出，请等待人工下载

2026/11/5 19:47:19 Book学术AI机器人收到请求，开始寻找文献

2026/11/5 19:47:19 已向机器人发送请求

8小时前

一条皮皮虫发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Is osteoarthritis a mitochondrial disease? What is the evidence.